EcoDrugPlus

Ensembl ID : ENSJJAG00000017426
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSJJAG00000016757
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSJJAG00000012837
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSJJAG00000015907
Gene Symbol: -
Cross references: -
114 Possible Orthologues:

Ensembl ID : ENSJJAG00000020766
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSJJAG00000020465
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSJJAG00000012170
Gene Symbol: -
Cross references: -
60 Possible Orthologues:

Ensembl ID : ENSJJAG00000020199
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Ensembl ID : ENSJJAG00000012709
Gene Symbol: -
Cross references: -
121 Possible Orthologues:

Ensembl ID : ENSJJAG00000020128
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSJJAG00000019736
Gene Symbol: -
Cross references: -
286 Possible Orthologues:

Ensembl ID : ENSJJAG00000017253
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).